Formulation of ternary complexes of glyburide with hydroxypropyl-β-cyclodextrin and other solubilizing agents and their effect on release behavior of glyburide in aqueous and buffered media at different agitation speeds

References

• http://en.wikipedia.org/wiki/Glibenclamide.
   Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413–420.
   PubMed Web of Science ®Google Scholar
• Jinno J, Oh D, Crison JR, Amidon GL. (2000). Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant. J Pharm Sci, 89:268–274.
   PubMed Web of Science ®Google Scholar
• Hoener B, Benet LZ, Banker GS, Rhodes CT. New York: Modern Pharmaceutics, Marcel Dekker, 1990:143.
   Google Scholar
• Jorgensen ED, Bhagwat. (1998). Pharm Sci Technol Today, 1:128–135.
   Google Scholar
• Kapsi SG, Ayres JW. (2001). Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability. Int J Pharm, 229:193–203.
   PubMed Web of Science ®Google Scholar
• Aguiar AJ, Zelmer AJ, Kinkel AW. (1979). Deagglomeration behavior of relatively insoluble benzoic acid and its sodium salt. J Pharm Sci, 56:1243–125.
   Web of Science ®Google Scholar
• Finholt P, Solvang S. (1968). Dissolution kinetics of drugs in human gastric juice–the role of surface tension. J Pharm Sci, 57:1322–1326.
   PubMed Web of Science ®Google Scholar
• Lin SL, Menig J, Lachman L. (1968). Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water insoluble drugs. J Pharm Sci, 57:2143–2148.
   PubMed Web of Science ®Google Scholar
• Duchêne D. (1987). In: Cyclodextrin and their Industrial Uses, Ed. de Santè, Paris.
   Google Scholar
• Szejli J. (1988). Cyclodextrin Technology. Dordrecht: Kluwer Academic Publishers.
   Google Scholar
• Uekama K, Hirayama F, Irie T. (1998). Cyclodextrin drug carrier systems. Chem Rev, 98:2045–2076.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. (1996). Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci, 85:1017–1025.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Fridriksdóttir H, Sigurdardóttir AM, Ueda H. (1994). The effect of water-soluble polymers on drug-cyclodextrin complexation. Int J Pharm, 110:169–177.
   Web of Science ®Google Scholar
• Ganzerli G, Van SL, Verschuren E, Ludwig A. (1996). Influence of β-cyclodextrin and various polysaccharides on the solubility of fluorescein and on the rheological and mucoadhesive properties of ophtalmic solutions. Pharmazie, 51:357–362.
   Web of Science ®Google Scholar
• Loftsson T, Gudmundsdóttir TK, Fridriksdóttir F. (1996). The influence of water-soluble polymers and pH on hydroxypropyl-cyclodextrin complexation of drugs. Drug Dev Ind Pharm, 22:401–405.
   Web of Science ®Google Scholar
• Redenti E, Szente L, Szejtli J. (2000). Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications. J Pharm Sci, 89:1–8.
   PubMed Web of Science ®Google Scholar
• Mura P, Faucci MT, Manderioli A, Bramanti G. (2001). Multicomponent systems of econazole with hydroxyacids and cyclodextrins. J Incl Phen, 39:131–138.
   Web of Science ®Google Scholar
• Redenti E, Szente L, Szejtli J. (2001). Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications. J Pharm Sci, 90:979–986.
   PubMed Web of Science ®Google Scholar
• Vikmon M, Kolbe I, Szejtli J, Redenti E, Ventura P. (1999). Preparation and characterization of piroxicam alkali-salt γ-cyclodextrin complexes. Proceedings 9th Intern. Symp. Cyclodextrins. Dordrecht: Kluwer Academic Publishers, pp 281–284.
   Google Scholar
• Piel G, Pirotte B, Delneuville I, Neven P, Llabres G, Delarge J et al. (1997). Study of the influence of both cyclodextrins and L-lysine on the aqueous solubility of nimesulide; isolation and characterization of nimesulide-L-lysine-cyclodextrin complexes. J Pharm Sci, 86:475–480.
   PubMed Web of Science ®Google Scholar
• Mura P, Faucci MT, Bettinetti GP. (2001). The effect of polyvinyl pyrrolidone on hydroxypropyl-β-cyclodextrin complexation with naproxen. Eur J Pharm Sci, 13:187–194.
   PubMed Web of Science ®Google Scholar
• Zerrouk N, Corti G, Ancillotti S, Maestrelli F, Cirri M, Mura P. (2006). Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability. Eur J Pharm Biopharm, 62:241–246.
   PubMed Web of Science ®Google Scholar
• Klein S, Wempe MF, Zoeller T, Buchanan NL, Lambert JL, Ramsey MG et al. (2009). Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-β-cyclodextrin. J Pharm Pharmacol, 61:23–30.
   PubMed Web of Science ®Google Scholar
• Klein S, Zoeller T. Improving Solubility and Dissolution of Glyburide: Solid Dispersions, Binary and Ternary Cyclodextrin Complexes. AAPS 2009; AAPS Annual Meeting and Exposition 11/7/2009–11/12/200.
   Google Scholar
• Higuchi T, Connors K. (1965). Phase-solubility techniques. Adv Anal Chem Instrum, 4:117–212.
   Google Scholar
• Costa P. (2001). An alternative method to the evaluation of similarity factor in dissolution testing. Int J Pharm, 220:77–83.
   PubMed Web of Science ®Google Scholar
• Morris KR, Fakes MG, Thakur AB, Newman AW, Singh AK, Venit JJ, Spagnuolo CJ, Serajuddin ATM. (1994). An integrated approach to the selection of optimal salt form for a new drug candidate. Int J Pharm, 105:209–217.
   Web of Science ®Google Scholar
• Berge SM, Bighley LD, Monkhouse DC. (1977). Pharmaceutical salts. J Pharm Sci, 66:1–19.
   PubMed Web of Science ®Google Scholar
• Laveneziana D, Speranza R, Raulli P, Paredi G.(1996). Ibuprofen-arginine in the management of pain. Clin Drug Invest, 11:1–7.
   Web of Science ®Google Scholar
• Krishnamoorthy R, Mitra AK. (1996). Complexation of weak acids and bases with cyclodextrins: effects of substrate ionization on the estimation and interpretation of association constants. Int J Pharm Adv, 1:330–343.
   Google Scholar
• Loftsson T, Olafsdottir B, Frioriksdottir H, Jònsdòttir S. (1993). Cyclodextrin complexation of NSAIDs: physicochemical characteristics. Eur J Pharm Sci, 1:95–101.
   Web of Science ®Google Scholar
• Steiner T, Koellner G, Gessler K, Saenger W. (1995). Isostructural replacement of a N-H… O by a C-H… O hydrogen bond in complex stabilisation: crystal structures of β-cyclodextrin complexed with diethanolamine and with pentane-1,5-diol. J Chem Soc Chem Commun, 511–512.
   Google Scholar
• United States Pharmacopeia and National Formulary USP 30–NF 25. The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2007; pp 3179–3180.
   Google Scholar
• Leeson JL. (2000). Some Observations on ‘Rethinking the Use of Water as Dissolution Medium’ Dissolution Technol, 7:16–17.
   Google Scholar
• Mura P, Adragna E, Rabasco AM, Moyano JR, Pérez-Martìnez JI, Arias MJ et al. (1999). Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems. Drug Dev Ind Pharm, 25:279–287.
   PubMed Web of Science ®Google Scholar
• Bayomi MA, Abanumay KA, Al-Angary AA. (2002). Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state. Int J Pharm, 243:107–117.
   PubMed Web of Science ®Google Scholar
• Manosroi J, Apriyani MG, Foe K, Manosroi A. (2005). Enhancement of the release of azelaic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-β-cyclodextrin. Int J Pharm, 293:235–240.
   PubMed Web of Science ®Google Scholar
• Ribeiro LS, Ferreira DC, Veiga FJ. (2003). Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with beta-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. Eur J Pharm Sci, 20:253–266.
   PubMed Web of Science ®Google Scholar
• Williams RO 3rd, Mahaguna V, Sriwongjanya M. (1998). Characterization of an inclusion complex of cholesterol and hydroxypropyl-β-cyclodextrin. Eur J Pharm Biopharm 46:355–360.
   PubMed Web of Science ®Google Scholar